The impact of hospital type on the efficacy of chemotherapy treatment in ovarian cancer patients (Q84623190)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

title

The impact of hospital type on the efficacy of chemotherapy treatment in ovarian cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

Flora Vernooij

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Petronella O Witteveen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Eva Verweij

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

Yolanda van der Graaf

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

A Peter M Heintz

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

publication date

3 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

volume

115

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

page(s)

343-348

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

Management and survival of ovarian cancer patients in South East England

9 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

The effect of centralization of primary surgery on survival in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2009.08.018

10.1016/J.YGYNO.2009.08.018

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19800674%20AND%20SRC:MED&resulttype=core&format=json

9 February 2020

1 reference